{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:29:25Z","timestamp":1790152165315,"version":"4.0.1"},"reference-count":119,"publisher":"Japan Society of Smooth Muscle Research","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Smooth Muscle Res.","J Smooth Muscle Res"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1540\/jsmr.54.100","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T17:41:08Z","timestamp":1550598068000},"page":"100-118","source":"Crossref","is-referenced-by-count":31,"title":["The impact of Pompe disease on smooth muscle: a review"],"prefix":"10.1540","volume":"54","author":[{"given":"Angela L.","family":"MCCALL","sequence":"first","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Duke University, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"SALEMI","sequence":"additional","affiliation":[{"name":"University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"BHANAP","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Duke University, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"STRICKLAND","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Duke University, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai K.","family":"ELMALLAH","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Duke University, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"435","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hers, HG. alpha-Glucosidase deficiency in generalized glycogenstorage disease (Pompe\u2019s disease). Biochem J. 1963; 86: 11\u20136.","DOI":"10.1042\/bj0860011"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. van den Hout, HMP, Hop, W, van Diggelen, OP, Smeitink, JAM, Smit, GPA, Poll-The, BTT, Bakker, HD, Loonen, MCB, de Klerk, JBC, Reuser, AJJ, van der Ploeg, AT. The natural course of infantile Pompe\u2019s disease: 20 original cases compared with 133 cases from the literature. Pediatrics. 2003; 112(2): 332\u201340.","DOI":"10.1542\/peds.112.2.332"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kishnani, PS, Hwu, WL, Mandel, H, Nicolino, M, Yong, F, Corzo, D, Infantile-Onset Pompe Disease Natural History Study Group. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr. 2006; 148(5): 671\u20136.","DOI":"10.1016\/j.jpeds.2005.11.033"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kishnani, PS, Steiner, RD, Bali, D, Berger, K, Byrne, BJ, Case, LE, Crowley, JF, Downs, S, Howell, RR, Kravitz, RM, Mackey, J, Marsden, D, Martins, AM, Millington, DS, Nicolino, M, O\u2019Grady, G, Patterson, MC, Rapoport, DM, Slonim, A, Spencer, CT, Tifft, CJ, Watson, MS. Pompe disease diagnosis and management guideline. Genet Med. 2006; 8(5): 267\u201388.","DOI":"10.1097\/01.gim.0000218152.87434.f3"},{"key":"5","unstructured":"5. Beratis, NG, LaBadie, GU, Hirschhorn, K. Genetic heterogeneity in acid alpha-glucosidase deficiency. Am J Hum Genet. 1983; 35(1): 21\u201333."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Slonim, AE, Bulone, L, Ritz, S, Goldberg, T, Chen, A, Martiniuk, F. Identification of two subtypes of infantile acid maltase deficiency. J Pediatr. 2000; 137(2): 283\u20135.","DOI":"10.1067\/mpd.2000.107112"},{"key":"7","unstructured":"7. Reuser, AJ, Koster, JF, Hoogeveen, A, Galjaard, H. Biochemical, immunological, and cell genetic studies in glycogenosis type II. Am J Hum Genet. 1978; 30(2): 132\u201343."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Byrne, BJ, Kishnani, PS, Case, LE, Merlini, L, M\u00fcller-Felber, W, Prasad, S, van der Ploeg, A. Pompe disease: design, methodology, and early findings from the Pompe Registry. Mol Genet Metab. 2011; 103(1): 1\u201311.","DOI":"10.1016\/j.ymgme.2011.02.004"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Kroos, MA, Pomponio, RJ, Hagemans, MLC, Keulemans, JLM, Phipps, M, DeRiso, M, Palmer, RE, Ausems, MG, Van der Beek, NAME, Van Diggelen, OP, Halley, DJJ, Van der Ploeg, AT, Reuser, AJ. Broad spectrum of Pompe disease in patients with the same c.-32-13T-&gt;G haplotype. Neurology. 2007; 68(2): 110\u20135.","DOI":"10.1212\/01.wnl.0000252798.25690.76"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Wokke, JHJ, Escolar, DM, Pestronk, A, Jaffe, KM, Carter, GT, van den Berg, LH, Florence, JM, Mayhew, J, Skrinar, A, Corzo, D, Laforet, P. Clinical features of late-onset Pompe disease: a prospective cohort study. Muscle Nerve. 2008; 38(4): 1236\u201345.","DOI":"10.1002\/mus.21025"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hobson-Webb, LD, Proia, AD, Thurberg, BL, Banugaria, S, Prater, SN, Kishnani, PS. Autopsy findings in late-onset Pompe disease: a case report and systematic review of the literature. Mol Genet Metab. 2012; 106(4): 462\u20139.","DOI":"10.1016\/j.ymgme.2012.05.007"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Chancellor, AM, Warlow, CP, Webb, JN, Lucas, MG, Besley, GT, Broadhead, DM. Acid maltase deficiency presenting with a myopathy and exercise induced urinary incontinence in a 68 year old male. J Neurol Neurosurg Psychiatry. 1991; 54(7): 659\u201360.","DOI":"10.1136\/jnnp.54.7.659"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hagemans, MLC, Winkel, LPF, Van Doorn, PA, Hop, WJC, Loonen, MCB, Reuser, AJJ, Van der Ploeg, AT. Clinical manifestation and natural course of late-onset Pompe\u2019s disease in 54 Dutch patients. Brain. 2005; 128(Pt 3): 671\u20137.","DOI":"10.1093\/brain\/awh384"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Montagnese, F, Granata, F, Musumeci, O, Rodolico, C, Mondello, S, Barca, E, Cucinotta, M, Ciranni, A, Longo, M, Toscano, A. Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD). J Inherit Metab Dis. 2016; 39(3): 391\u20138.","DOI":"10.1007\/s10545-015-9913-x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Winkel, LPF, Hagemans, MLC, van Doorn, PA, Loonen, MCB, Hop, WJC, Reuser, AJ, van der Ploeg, AT. The natural course of non-classic Pompe\u2019s disease; a review of 225 published cases. J Neurol. 2005; 252(8): 875\u201384.","DOI":"10.1007\/s00415-005-0922-9"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Matsui, T, Kuroda, S, Mizutani, M, Kiuchi, Y, Suzuki, K, Ono, T. Generalized glycogen storage disease in Japanese quail (Coturnix coturnix japonica). Vet Pathol. 1983; 20(3): 312\u201321.","DOI":"10.1177\/030098588302000307"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sepp\u00e4l\u00e4, EH, Reuser, AJ, Lohi, H. A nonsense mutation in the acid \u03b1-glucosidase gene causes Pompe disease in Finnish and Swedish Lapphunds. PLoS One. 2013; 8(2): e56825.","DOI":"10.1371\/journal.pone.0056825"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Howell, JM, Dorling, PR, Cook, RD, Robinson, WF, Bradley, S, Gawthorne, JM. Infantile and late onset form of generalised glycogenosis type II in cattle. J Pathol. 1981; 134(4): 267\u201377.","DOI":"10.1002\/path.1711340403"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Jolly, RD, Van-de-Water, NS, Richards, RB, Dorling, PR. Generalized glycogenosis in beef shorthorn cattle--heterozygote detection. Aust J Exp Biol Med Sci. 1977; 55(2): 14U\u201350.","DOI":"10.1038\/icb.1977.11"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Manktelow, BW, Hartley, WJ. Generalized glycogen storage disease in sheep. J Comp Pathol. 1975; 85(1): 139\u201345.","DOI":"10.1016\/0021-9975(75)90092-4"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Walvoort, HC. Glycogen storage diseases in animals and their potential value as models of human disease. J Inherit Metab Dis. 1983; 6(1): 3\u201316.","DOI":"10.1007\/BF02391186"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Bijvoet, AGA, van de Kamp, EH, Kroos, MA, Ding, JH, Yang, BZ, Visser, P, Bakker, CE, Verbeet, MP, Oostra, BA, Reuser, AJ, van der Ploeg, AT. Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease. Hum Mol Genet. 1998; 7(1): 53\u201362.","DOI":"10.1093\/hmg\/7.1.53"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Raben, N, Lu, N, Nagaraju, K, Rivera, Y, Lee, A, Yan, B, Byrne, B, Meikle, PJ, Umapathysivam, K, Hopwood, JJ, Plotz, PH. Conditional tissue-specific expression of the acid alpha-glucosidase (GAA) gene in the GAA knockout mice: implications for therapy. Hum Mol Genet. 2001; 10(19): 2039\u201347.","DOI":"10.1093\/hmg\/10.19.2039"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Raben, N, Nagaraju, K, Lee, E, Kessler, P, Byrne, B, Lee, L, LaMarca, M, King, C, Ward, J, Sauer, B, Plotz, P. Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II. J Biol Chem. 1998; 273(30): 19086\u201392.","DOI":"10.1074\/jbc.273.30.19086"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Hug, G, Schubert, WK. Lysosomes in type II glycogenosis. Changes during administration of extract from Aspergillus niger. J Cell Biol. 1967; 35(1): C1\u20136.","DOI":"10.1083\/jcb.35.1.C1"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Van der Ploeg, AT, Loonen, MC, Bolhuis, PA, Busch, HM, Reuser, AJ, Galjaard, H. Receptor-mediated uptake of acid alpha-glucosidase corrects lysosomal glycogen storage in cultured skeletal muscle. Pediatr Res. 1988; 24(1): 90\u20134.","DOI":"10.1203\/00006450-198807000-00021"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Van der Ploeg, AT, Kroos, MA, Willemsen, R, Brons, NH, Reuser, AJ. Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice. J Clin Invest. 1991; 87(2): 513\u20138.","DOI":"10.1172\/JCI115025"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Van den Hout, H, Reuser, AJ, Vulto, AG, Loonen, MCB, Cromme-Dijkhuis, A, Van der Ploeg, AT. Recombinant human \u03b1-glucosidase from rabbit milk in Pompe patients. Lancet. 2000; 356(9227): 397\u20138.","DOI":"10.1016\/S0140-6736(00)02533-2"},{"key":"29","unstructured":"29. Amalfitano, A, Bengur, AR, Morse, RP, Majure, JM, Case, LE, Veerling, DL, Mackey, J, Kishnani, P, Smith, W, McVie-Wylie, A, Sullivan, JA, Hoganson, GE, Phillips, JA 3rd, Schaefer, GB, Charrow, J, Ware, RE, Bossen, EH, Chen, YT. Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial. Genet Med. 2001; 3(2): 132\u20138."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kishnani, PS, Corzo, D, Nicolino, M, Byrne, B, Mandel, H, Hwu, WL, Leslie, N, Levine, J, Spencer, C, McDonald, M, Li, J, Dumontier, J, Halberthal, M, Chien, YH, Hopkin, R, Vijayaraghavan, S, Gruskin, D, Bartholomew, D, van der Ploeg, A, Clancy, JP, Parini, R, Morin, G, Beck, M, De la Gastine, GS, Jokic, M, Thurberg, B, Richards, S, Bali, D, Davison, M, Worden, MA, Chen, YT, Wraith, JE. Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology. 2007; 68(2): 99\u2013109.","DOI":"10.1212\/01.wnl.0000251268.41188.04"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Nicolino, M, Byrne, B, Wraith, JE, Leslie, N, Mandel, H, Freyer, DR, Arnold, GL, Pivnick, EK, Ottinger, CJ, Robinson, PH, Loo, JCA, Smitka, M, Jardine, P, Tat\u00f2, L, Chabrol, B, McCandless, S, Kimura, S, Mehta, L, Bali, D, Skrinar, A, Morgan, C, Rangachari, L, Corzo, D, Kishnani, PS. Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease. Genet Med. 2009; 11(3): 210\u20139.","DOI":"10.1097\/GIM.0b013e31819d0996"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Kishnani, PS, Goldenberg, PC, DeArmey, SL, Heller, J, Benjamin, D, Young, S, Bali, D, Smith, SA, Li, JS, Mandel, H, Koeberl, D, Rosenberg, A, Chen, YT. Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants. Mol Genet Metab. 2010; 99(1): 26\u201333.","DOI":"10.1016\/j.ymgme.2009.08.003"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Shea, L, Raben, N. Autophagy in skeletal muscle: implications for Pompe disease. Int J Clin Pharmacol Ther. 2009; 47(Suppl 1): S42\u20137.","DOI":"10.5414\/CPP47042"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Byrne, BJ, Falk, DJ, Pacak, CA, Nayak, S, Herzog, RW, Elder, ME, Collins, SW, Conlon, TJ, Clement, N, Cleaver, BD, Cloutier, DA, Porvasnik, SL, Islam, S, Elmallah, MK, Martin, A, Smith, BK, Fuller, DD, Lawson, LA, Mah, CS. Pompe disease gene therapy. Hum Mol Genet. 2011; 20(R1): R61\u20138.","DOI":"10.1093\/hmg\/ddr174"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Keeler, AM, Zieger, M, Todeasa, SH, McCall, AL, Gifford, JC, Birsak, S, Choudhury, SR, Byrne, BJ, Sena-Esteves, M, ElMallah, MK. Systemic delivery of AAVB1-GAA clears glycogen and prolongs survival in a mouse model of Pompe disease. Hum Gene Ther. 2019; 30(1): 57\u201368.","DOI":"10.1089\/hum.2018.016"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Smith, BK, Collins, SW, Conlon, TJ, Mah, CS, Lawson, LA, Martin, AD, Fuller, DD, Cleaver, BD, Cl\u00e9ment, N, Phillips, D, Islam, S, Dobjia, N, Byrne, BJ. Phase I\/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes. Hum Gene Ther. 2013; 24(6): 630\u201340.","DOI":"10.1089\/hum.2012.250"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Corti, M, Liberati, C, Smith, BK, Lawson, LA, Tuna, IS, Conlon, TJ, Coleman, KE, Islam, S, Herzog, RW, Fuller, DD, Collins, SW, Byrne, BJ. Safety of Intradiaphragmatic Delivery of Adeno-Associated Virus-Mediated Alpha-Glucosidase (rAAV1-CMV-hGAA) Gene Therapy in Children Affected by Pompe Disease. Hum Gene Ther Clin Dev. 2017; 28(4): 208\u201318.","DOI":"10.1089\/humc.2017.146"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Corti, M, Cleaver, B, Cl\u00e9ment, N, Conlon, TJ, Faris, KJ, Wang, G, Benson, J, Tarantal, AF, Fuller, D, Herzog, RW, Byrne, BJ. Evaluation of Readministration of a Recombinant Adeno-Associated Virus Vector Expressing Acid Alpha-Glucosidase in Pompe Disease: Preclinical to Clinical Planning. Hum Gene Ther Clin Dev. 2015; 26(3): 185\u201393.","DOI":"10.1089\/humc.2015.068"},{"key":"39","unstructured":"39. Bond, JE, Kishnani, PS, Koeberl, DD. Immunomodulatory, liver depot gene therapy for Pompe disease. Cell Immunol. 2017; S0008-8749(17)30238-1."},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Fuller, DD, ElMallah, MK, Smith, BK, Corti, M, Lawson, LA, Falk, DJ, Byrne, BJ. The respiratory neuromuscular system in Pompe disease. Respir Physiol Neurobiol. 2013; 189(2): 241\u20139.","DOI":"10.1016\/j.resp.2013.06.007"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Hagemans, MLC, Winkel, LPF, Hop, WCJ, Reuser, AJ, Van Doorn, PA, Van der Ploeg, AT. Disease severity in children and adults with Pompe disease related to age and disease duration. Neurology. 2005; 64(12): 2139\u201341.","DOI":"10.1212\/01.WNL.0000165979.46537.56"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Haley, SM, Fragala, MA, Skrinar, AM. Pompe disease and physical disability. Dev Med Child Neurol. 2003; 45(9): 618\u201323.","DOI":"10.1111\/j.1469-8749.2003.tb00966.x"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Marsden, D. Infantile onset Pompe disease: a report of physician narratives from an epidemiologic study. Genet Med. 2005; 7(2): 147\u201350.","DOI":"10.1097\/01.GIM.0000154301.76619.5C"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. DeRuisseau, LR, Fuller, DD, Qiu, K, DeRuisseau, KC, Donnelly, WH Jr, Mah, C, Reier, PJ, Byrne, BJ. Neural deficits contribute to respiratory insufficiency in Pompe disease. Proc Natl Acad Sci USA. 2009; 106(23): 9419\u201324.","DOI":"10.1073\/pnas.0902534106"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. ElMallah, MK, Falk, DJ, Lane, MA, Conlon, TJ, Lee, KZ, Shafi, NI, Reier, PJ, Byrne, BJ, Fuller, DD. Retrograde gene delivery to hypoglossal motoneurons using adeno-associated virus serotype 9. Hum Gene Ther Methods. 2012; 23(2): 148\u201356.","DOI":"10.1089\/hgtb.2012.009"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Lee, KZ, Qiu, K, Sandhu, MS, Elmallah, MK, Falk, DJ, Lane, MA, Reier, PJ, Byrne, BJ, Fuller, DD. Hypoglossal neuropathology and respiratory activity in pompe mice. Front Physiol. 2011; 2: 31.","DOI":"10.3389\/fphys.2011.00031"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Turner, SM, Hoyt, AK, ElMallah, MK, Falk, DJ, Byrne, BJ, Fuller, DD. Neuropathology in respiratory-related motoneurons in young Pompe (Gaa(-\/-)) mice. Respir Physiol Neurobiol. 2016; 227: 48\u201355.","DOI":"10.1016\/j.resp.2016.02.007"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Elmallah, MK, Falk, DJ, Nayak, S, Federico, RA, Sandhu, MS, Poirier, A, Byrne, BJ, Fuller, DD. Sustained correction of motoneuron histopathology following intramuscular delivery of AAV in pompe mice. Mol Ther. 2014; 22(4): 702\u201312.","DOI":"10.1038\/mt.2013.282"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Yang, CF, Niu, DM, Jeng, MJ, Lee, YS, Taso, PC, Soong, WJ. Late-onset Pompe disease with left-sided bronchomalacia. Respir Care. 2015; 60(2): e26\u20139.","DOI":"10.4187\/respcare.03419"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Fukuhara, Y, Fuji, N, Yamazaki, N, Hirakiyama, A, Kamioka, T, Seo, JH, Mashima, R, Kosuga, M, Okuyama, T. A molecular analysis of the GAA gene and clinical spectrum in 38 patients with Pompe disease in Japan. Mol Genet Metab Rep. 2017; 14: 3\u20139.","DOI":"10.1016\/j.ymgmr.2017.10.009"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Ito, T, Sasaki, T, Ono, I. Secondary endocardial fibroelastosis associated with Pompe disease and multicystic dysplastic kidney. Heart Vessels. 2000; 15(5): 240\u20132.","DOI":"10.1007\/s003800070014"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Kobayashi, H, Shimada, Y, Ikegami, M, Kawai, T, Sakurai, K, Urashima, T, Ijima, M, Fujiwara, M, Kaneshiro, E, Ohashi, T, Eto, Y, Ishigaki, K, Osawa, M, Kyosen, SO, Ida, H. Prognostic factors for the late onset Pompe disease with enzyme replacement therapy: from our experience of 4 cases including an autopsy case. Mol Genet Metab. 2010; 100(1): 14\u20139.","DOI":"10.1016\/j.ymgme.2010.01.015"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Baqir, M, Ryu, JH, Sorenson, EJ, Olson, EJ. A. A 62-year-old man with dyspnea. Respir Med Case Rep. 2016; 17: 50\u20133 .","DOI":"10.1016\/j.rmcr.2016.01.003"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Bernstein, DL, Bialer, MG, Mehta, L, Desnick, RJ. Pompe disease: dramatic improvement in gastrointestinal function following enzyme replacement therapy. A report of three later-onset patients. Mol Genet Metab. 2010; 101(2-3): 130\u20133.","DOI":"10.1016\/j.ymgme.2010.06.003"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Burrow, TA, Bailey, LA, Kinnett, DG, Hopkin, RJ. Acute progression of neuromuscular findings in infantile Pompe disease. Pediatr Neurol. 2010; 42(6): 455\u20138.","DOI":"10.1016\/j.pediatrneurol.2010.02.006"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Bembi, B, Cerini, E, Danesino, C, Donati, MA, Gasperini, S, Morandi, L, Musumeci, O, Parenti, G, Ravaglia, S, Seidita, F, Toscano, A, Vianello, A. Management and treatment of glycogenosis type II. Neurology. 2008; 71(23 Suppl 2): S12\u201336.","DOI":"10.1212\/WNL.0b013e31818da93f"},{"key":"57","unstructured":"57. Boentert, M, Karabul, N, Wenninger, S, Stubbe-Dr\u00e4ger, B, Mengel, E, Schoser, B, Young, P. Sleep-related symptoms and sleep-disordered breathing in adult Pompe disease. Eur J Neurol. 2015; 22(2): 369\u201376, e27."},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Chan, JYC, Stern, DA, Guerra, S, Wright, AL, Morgan, WJ, Martinez, FD. Pneumonia in childhood and impaired lung function in adults: a longitudinal study. Pediatrics. 2015; 135(4): 607\u201316.","DOI":"10.1542\/peds.2014-3060"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Boentert, M, Dr\u00e4ger, B, Glatz, C, Young, P. Sleep-disordered breathing and effects of noninvasive ventilation in patients with late-onset pompe disease. J Clin Sleep Med. 2016; 12(12): 1623\u201332.","DOI":"10.5664\/jcsm.6346"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Trottier, SJ, Ritter, S, Lakshmanan, R, Sakabu, SA, Troop, BR. Percutaneous tracheostomy tube obstruction: warning. Chest. 2002; 122(4): 1377\u201381.","DOI":"10.1378\/chest.122.4.1377"},{"key":"61","doi-asserted-by":"publisher","unstructured":"61. Fikkers, BG, van Veen, JA, Kooloos, JG, Pickkers, P, van den Hoogen, FJA, Hillen, B, van der Hoeven, JG. Emphysema and pneumothorax after percutaneous tracheostomy: case reports and an anatomic study. Chest. 2004; 125(5): 1805\u201314.","DOI":"10.1378\/chest.125.5.1805"},{"issue":"12","key":"62","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1002\/lary.26668","volume":"127","year":"2017","unstructured":"62. Spataro, E, Durakovic, N, Kallogjeri, D, Nussenbaum, B. Complications and 30-day hospital readmission rates of patients undergoing tracheostomy: A prospective analysis. Laryngoscope. 2017; 127(12): 2746\u201353.","journal-title":"The Laryngoscope","ISSN":"https:\/\/id.crossref.org\/issn\/0023-852X","issn-type":"print"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Mah, C, Fraites, TJ Jr, Cresawn, KO, Zolotukhin, I, Lewis, MA, Byrne, BJ. A new method for recombinant adeno-associated virus vector delivery to murine diaphragm. Mol Ther. 2004; 9(3): 458\u201363.","DOI":"10.1016\/j.ymthe.2004.01.006"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Falk, DJ, Mah, CS, Soustek, MS, Lee, KZ, Elmallah, MK, Cloutier, DA, Fuller, DD, Byrne, BJ. Intrapleural administration of AAV9 improves neural and cardiorespiratory function in Pompe disease. Mol Ther. 2013; 21(9): 1661\u20137.","DOI":"10.1038\/mt.2013.96"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Pena, LDM, Proia, AD, Kishnani, PS. Postmortem Findings and Clinical Correlates in Individuals with Infantile-Onset Pompe Disease. JIMD reports, vol. 23. Springer; 2015. p. 45\u201354.","DOI":"10.1007\/8904_2015_426"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Keeler, AM, Liu, D, Zieger, M, Xiong, L, Salemi, J, Bellv\u00e9, K, Byrne, BJ, Fuller, DD, ZhuGe, R, ElMallah, MK. Airway smooth muscle dysfunction in Pompe (<i>Gaa<sup>-\/-<\/sup><\/i> ) mice. Am J Physiol Lung Cell Mol Physiol. 2017; 312(6): L873\u201381.","DOI":"10.1152\/ajplung.00568.2016"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Bijvoet, AGA, Van Hirtum, H, Vermey, M, Van Leenen, D, Van Der Ploeg, AT, Mooi, WJ, Reuser, AJ. Pathological features of glycogen storage disease type II highlighted in the knockout mouse model. J Pathol. 1999; 189(3): 416\u201324.","DOI":"10.1002\/(SICI)1096-9896(199911)189:3<416::AID-PATH445>3.0.CO;2-6"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Masters, IB, Zimmerman, PV, Pandeya, N, Petsky, HL, Wilson, SB, Chang, AB. Quantified tracheobronchomalacia disorders and their clinical profiles in children. Chest. 2008; 133(2): 461\u20137.","DOI":"10.1378\/chest.07-2283"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Brenn, BR, Theroux, MT, Shah, SA, Mackenzie, WG, Heinle, R, Scavina, MT. Critical Airway Stenosis in an Adolescent Male With Pompe Disease and Thoracic Lordosis: A Case Report. A Case Rep. 2017; 9(7): 199\u2013203.","DOI":"10.1213\/XAA.0000000000000564"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. van der Ploeg, AT, Clemens, PR, Corzo, D, Escolar, DM, Florence, J, Groeneveld, GJ, Herson, S, Kishnani, PS, Laforet, P, Lake, SL, Lange, DJ, Leshner, RT, Mayhew, JE, Morgan, C, Nozaki, K, Park, DJ, Pestronk, A, Rosenbloom, B, Skrinar, A, van Capelle, CI, van der Beek, NAME, Wasserstein, M, Zivkovic, SA. A randomized study of alglucosidase alfa in late-onset Pompe\u2019s disease. N Engl J Med. 2010; 362(15): 1396\u2013406.","DOI":"10.1056\/NEJMoa0909859"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Anderson, LJ, Henley, W, Wyatt, KM, Nikolaou, V, Waldek, S, Hughes, DA, Lachmann, RH, Logan, S. Effectiveness of enzyme replacement therapy in adults with late-onset Pompe disease: results from the NCS-LSD cohort study. J Inherit Metab Dis. 2014; 37(6): 945\u201352.","DOI":"10.1007\/s10545-014-9728-1"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Richards, RB, Edwards, JR, Cook, RD, White, RR. Bovine Generalized Glyocogenosis. Neuropathol Appl Neurobiol. 1977; 3(1): 45\u201356.","DOI":"10.1111\/j.1365-2990.1977.tb00568.x"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. de Gijt, JP, van Capelle, CI, Oosterhuis, JW, van der Ploeg, AT, van der Wal, KGH. Gingival overgrowth in Pompe disease: a case report. J Oral Maxillofac Surg. 2011; 69(8): 2186\u201390.","DOI":"10.1016\/j.joms.2011.03.070"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Refai, D, Lev, R, Cross, DT, Shimony, JS, Leonard, JR. Thrombotic complications of a basilar artery aneurysm in a young adult with Pompe disease. Surg Neurol. 2008; 70(5): 518\u201320.","DOI":"10.1016\/j.surneu.2007.05.049"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Quenardelle, V, Bataillard, M, Bazin, D, Lannes, B, Wolff, V, Echaniz-Laguna, A. Pompe disease presenting as an isolated generalized dilative arteriopathy with repeated brain and kidney infarcts. J Neurol. 2015; 262(2): 473\u20135.","DOI":"10.1007\/s00415-014-7582-6"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Hensel, O, Hanisch, F, Stock, K, Stoevesandt, D, Deschauer, M, M\u00fcller, T. Morphology and function of cerebral arteries in adults with pompe disease. JIMD Rep. 2015; 20: 27\u201333.","DOI":"10.1007\/8904_2014_385"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Pappa, E, Papadopoulos, C, Grimbert, P, Lafor\u00eat, P, Bassez, G. Renal artery fibromuscular dysplasia in Pompe disease: A case report. Mol Genet Metab Rep. 2018; 16: 64\u20135.","DOI":"10.1016\/j.ymgmr.2018.07.002"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Pichiecchio, A, Sacco, S, De Filippi, P, Caverzasi, E, Ravaglia, S, Bastianello, S, Danesino, C. Late-onset Pompe disease: a genetic-radiological correlation on cerebral vascular anomalies. J Neurol. 2017; 264(10): 2110\u20138.","DOI":"10.1007\/s00415-017-8601-1"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Huded, V, Bohra, V, Prajapati, J, DeSouza, R, Ramankutty, R. Stroke in Young-Dilative Arteriopathy: A Clue to Late-Onset Pompe\u2019s Disease? J Stroke Cerebrovasc Dis. 2016; 25(4): e50\u20132.","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.01.021"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80. Lafor\u00eat, P, Petiot, P, Nicolino, M, Orlikowski, D, Caillaud, C, Pellegrini, N, Froissart, R, Petitjean, T, Maire, I, Chabriat, H, Hadrane, L, Annane, D, Eymard, B. Dilative arteriopathy and basilar artery dolichoectasia complicating late-onset Pompe disease. Neurology. 2008; 70(22): 2063\u20136.","DOI":"10.1212\/01.wnl.0000313367.09469.13"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. Miyamoto, Y, Etoh, Y, Joh, R, Noda, K, Ohya, I, Morimatsu, M. Adult-onset acid maltase deficiency in siblings. Acta Pathol Jpn. 1985; 35(6): 1533\u201342.","DOI":"10.1111\/j.1440-1827.1985.tb01450.x"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. Makos, MM, McComb, RD, Hart, MN, Bennett, DR. Alpha-glucosidase deficiency and basilar artery aneurysm: report of a sibship. Ann Neurol. 1987; 22(5): 629\u201333.","DOI":"10.1002\/ana.410220512"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83. Braunsdorf, WE. Fusiform aneurysm of basilar artery and ectatic internal carotid arteries associated with glycogenosis type 2 (Pompe\u2019s disease). Neurosurgery. 1987; 21(5): 748\u20139.","DOI":"10.1227\/00006123-198711000-00030"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84. Matsuoka, Y, Senda, Y, Hirayama, M, Matsui, T, Takahashi, A. Late-onset acid maltase deficiency associated with intracranial aneurysm. J Neurol. 1988; 235(6): 371\u20133.","DOI":"10.1007\/BF00314237"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85. Zhang, B, Zhao, Y, Liu, J, Li, L, Shan, J, Zhao, D, Yan, C. Late-onset Pompe disease with complicated intracranial aneurysm: a Chinese case report. Neuropsychiatr Dis Treat. 2016; 12: 713\u20137.","DOI":"10.2147\/NDT.S94892"},{"key":"86","unstructured":"86. Sandhu, D, Rizvi, A, Kim, J, Reshi, R. Diffuse cerebral microhemorrhages in a patient with adult-onset Pompe\u2019s disease: a case report. J Vasc Interv Neurol. 2014; 7(5): 82\u20135."},{"key":"87","doi-asserted-by":"crossref","unstructured":"87. Anneser, JMH, Pongratz, DE, Podskarbi, T, Shin, YS, Schoser, BGH. Mutations in the acid \u03b1-glucosidase gene (M. Pompe) in a patient with an unusual phenotype. Neurology. 2005; 64(2): 368\u201370.","DOI":"10.1212\/01.WNL.0000149528.95362.20"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88. El-Gharbawy, AH, Bhat, G, Murillo, JE, Thurberg, BL, Kampmann, C, Mengel, KEE, Kishnani, PS. Expanding the clinical spectrum of late-onset Pompe disease: dilated arteriopathy involving the thoracic aorta, a novel vascular phenotype uncovered. Mol Genet Metab. 2011; 103(4): 362\u20136.","DOI":"10.1016\/j.ymgme.2011.04.009"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89. Nemes, A, Soliman, OII, Geleijnse, ML, Anwar, AM, van der Beek, NAME, van Doorn, PA, Gavall\u00e9r, H, Csajb\u00f3k, E, ten Cate, FJ. Increased aortic stiffness in glycogenosis type 2 (Pompe\u2019s disease). Int J Cardiol. 2007; 120(1): 138\u201341.","DOI":"10.1016\/j.ijcard.2006.07.215"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90. Clement, DH, Godman, GC. Glycogen disease resembling mongolism, cretinism, and amytonia congenita; case report and review of literature. J Pediatr. 1950; 36(1): 11\u201330 illust.","DOI":"10.1016\/S0022-3476(50)80174-9"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91. Sacconi, S, Bocquet, JD, Chanalet, S, Tanant, V, Salviati, L, Desnuelle, C. Abnormalities of cerebral arteries are frequent in patients with late-onset Pompe disease. J Neurol. 2010; 257(10): 1730\u20133.","DOI":"10.1007\/s00415-010-5618-0"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92. Goeber, V, Banz, Y, Kaeberich, A, Carrel, T. Huge aneurysm of the ascending aorta in a patient with adult-type Pompe\u2019s disease: histological findings mimicking fibrillinopathy. Eur J Cardiothorac Surg. 2013; 43(1): 193\u20135.","DOI":"10.1093\/ejcts\/ezs489"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93. Kretzschmar, HA, Wagner, H, H\u00fcbner, G, Danek, A, Witt, TN, Mehraein, P. Aneurysms and vacuolar degeneration of cerebral arteries in late-onset acid maltase deficiency. J Neurol Sci. 1990; 98(2-3): 169\u201383.","DOI":"10.1016\/0022-510X(90)90258-O"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94. Van den Hout, JM, Kamphoven, JHJ, Winkel, LPF, Arts, WFM, De Klerk, JBC, Loonen, MC, Vulto, AG, Cromme-Dijkhuis, A, Weisglas-Kuperus, N, Hop, W, Van Hirtum, H, Van Diggelen, OP, Boer, M, Kroos, MA, Van Doorn, PA, Van der Voort, E, Sibbles, B, Van Corven, EJ, Brakenhoff, JP, Van Hove, J, Smeitink, JA, de Jong, G, Reuser, AJ, Van der Ploeg, AT. Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. Pediatrics. 2004; 113(5): e448\u201357.","DOI":"10.1542\/peds.113.5.e448"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95. Wens, SCA, Kuperus, E, Mattace-Raso, FUS, Kruijshaar, ME, Brusse, E, van Montfort, KCAGM, de Boer, MS, Sijbrands, EJG, van der Ploeg, AT, van Doorn, PA. Increased aortic stiffness and blood pressure in non-classic Pompe disease. J Inherit Metab Dis. 2014; 37(3): 391\u20137 .","DOI":"10.1007\/s10545-013-9667-2"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96. Bijvoet, AGA, Van Hirtum, H, Kroos, MA, Van de Kamp, EH, Schoneveld, O, Visser, P, Brakenhoff, JPJ, Weggeman, M, van Corven, EJ, Van der Ploeg, AT, Reuser, AJ. Human acid alpha-glucosidase from rabbit milk has therapeutic effect in mice with glycogen storage disease type II. Hum Mol Genet. 1999; 8(12): 2145\u201353.","DOI":"10.1093\/hmg\/8.12.2145"},{"key":"97","doi-asserted-by":"crossref","unstructured":"97. Prater, SN, Banugaria, SG, DeArmey, SM, Botha, EG, Stege, EM, Case, LE, Jones, HN, Phornphutkul, C, Wang, RY, Young, SP, Kishnani, PS. The emerging phenotype of long-term survivors with infantile Pompe disease. Genet Med. 2012; 14(9): 800\u201310.","DOI":"10.1038\/gim.2012.44"},{"key":"98","doi-asserted-by":"crossref","unstructured":"98. Jones, HN, Muller, CW, Lin, M, Banugaria, SG, Case, LE, Li, JS, O\u2019Grady, G, Heller, JH, Kishnani, PS. Oropharyngeal dysphagia in infants and children with infantile Pompe disease. Dysphagia. 2010; 25(4): 277\u201383.","DOI":"10.1007\/s00455-009-9252-x"},{"key":"99","doi-asserted-by":"crossref","unstructured":"99. Karabul, N, Skudlarek, A, Berndt, J, Kornblum, C, Kley, RA, Wenninger, S, Tiling, N, Mengel, E, Pl\u00f6ckinger, U, Vorgerd, M, Deschauer, M, Schoser, B, Hanisch, F. Urge incontinence and gastrointestinal symptoms in adult patients with pompe disease: a cross-sectional survey. JIMD Rep. 2014; 17: 53\u201361.","DOI":"10.1007\/8904_2014_334"},{"key":"100","doi-asserted-by":"crossref","unstructured":"100. van der Walt, JD, Swash, M, Leake, J, Cox, EL. The pattern of involvement of adult-onset acid maltase deficiency at autopsy. Muscle Nerve. 1987; 10(3): 272\u201381.","DOI":"10.1002\/mus.880100311"},{"key":"101","doi-asserted-by":"crossref","unstructured":"101. Walvoort, HC, Dormans, JAMA, van den Ingh, TS. Comparative pathology of the canine model of glycogen storage disease type II (Pompe\u2019s disease). J Inherit Metab Dis. 1985; 8(1): 38\u201346.","DOI":"10.1007\/BF01805484"},{"key":"102","doi-asserted-by":"crossref","unstructured":"102. Remiche, G, Herbaut, AG, Ronchi, D, Lamperti, C, Magri, F, Moggio, M, Bresolin, N, Comi, GP. Incontinence in late-onset Pompe disease: an underdiagnosed treatable condition. Eur Neurol. 2012; 68(2): 75\u20138.","DOI":"10.1159\/000338776"},{"key":"103","doi-asserted-by":"crossref","unstructured":"103. Gesqui\u00e8re-Dando, A, Attarian, S, Maues De Paula, A, Pouget, J, Salort-Campana, E. Fibromyalgia-like symptoms associated with irritable bowel syndrome: A challenging diagnosis of late-onset Pompe disease. Muscle Nerve. 2015; 52(2): 300\u20134.","DOI":"10.1002\/mus.24618"},{"key":"104","doi-asserted-by":"crossref","unstructured":"104. Pardo, J, Garc\u00eda-Sobrino, T, L\u00f3pez-Ferreiro, A. S\u00edntomas gastrointestinales en la enfermedad de Pompe de inicio tard\u00edo: respuesta r\u00e1pida a la terapia sustitutiva enzim\u00e1tica. Gastrointest Symptoms Late-onset Pompe Dis Early Response Enzyme Replacement Ther J Neurol Sci. 2015; 353(1\u20132): 181\u20132 .","DOI":"10.1016\/j.jns.2015.04.012"},{"key":"105","doi-asserted-by":"crossref","unstructured":"105. Thurberg, BL, Lynch Maloney, C, Vaccaro, C, Afonso, K, Tsai, ACH, Bossen, E, Kishnani, PS, O\u2019Callaghan, M. Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease. Lab Invest. 2006; 86(12): 1208\u201320.","DOI":"10.1038\/labinvest.3700484"},{"key":"106","doi-asserted-by":"crossref","unstructured":"106. McNamara, ER, Austin, S, Case, L, Wiener, JS, Peterson, AC, Kishnani, PS. Expanding our understanding of lower urinary tract symptoms and incontinence in adults with pompe disease. JIMD Rep. 2015; 20: 5\u201310.","DOI":"10.1007\/8904_2014_381"},{"key":"107","doi-asserted-by":"crossref","unstructured":"107. Ajay, D, McNamara, ER, Austin, S, Wiener, JS, Kishnani, P. Lower Urinary Tract Symptoms and Incontinence in Children with Pompe Disease. JIMD Rep. 2016; 28: 59\u201367.","DOI":"10.1007\/8904_2015_492"},{"key":"108","doi-asserted-by":"crossref","unstructured":"108. Prakalapakorn, SG, Proia, AD, Yanovitch, TL, DeArmey, S, Mendelsohn, NJ, Aleck, KA, Kishnani, PS. Ocular and histologic findings in a series of children with infantile pompe disease treated with enzyme replacement therapy. J Pediatr Ophthalmol Strabismus. 2014; 51(6): 355\u201362.","DOI":"10.3928\/01913913-20140813-01"},{"key":"109","doi-asserted-by":"crossref","unstructured":"109. Katona, I, Weis, J, Hanisch, F. Glycogenosome accumulation in the arrector pili muscle in Pompe disease. Orphanet J Rare Dis. 2014; 9(1): 17.","DOI":"10.1186\/1750-1172-9-17"},{"key":"110","doi-asserted-by":"crossref","unstructured":"110. van der Meijden, JC, Kruijshaar, ME, Harlaar, L, Rizopoulos, D, van der Beek, NAME, van der Ploeg, AT. Long-term follow-up of 17 patients with childhood Pompe disease treated with enzyme replacement therapy. J Inherit Metab Dis. 2018; 41(6): 1205\u201314.","DOI":"10.1007\/s10545-018-0166-3"},{"key":"111","doi-asserted-by":"crossref","unstructured":"111. Ripolone, M, Violano, R, Ronchi, D, Mondello, S, Nascimbeni, A, Colombo, I, Fagiolari, G, Bordoni, A, Fortunato, F, Lucchini, V, Saredi, S, Filosto, M, Musumeci, O, Tonin, P, Mongini, T, Previtali, S, Morandi, L, Angelini, C, Mora, M, Sandri, M, Sciacco, M, Toscano, A, Comi, GP, Moggio, M. Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD). Neuropathol Appl Neurobiol. 2017.","DOI":"10.1111\/nan.12414"},{"key":"112","doi-asserted-by":"crossref","unstructured":"112. Chen, M, Zhang, L, Quan, S. Enzyme replacement therapy for infantile-onset Pompe disease. Cochrane Database Syst Rev. 2017; 11: CD011539 .","DOI":"10.1002\/14651858.CD011539.pub2"},{"key":"113","doi-asserted-by":"crossref","unstructured":"113. Gaeta, M, Barca, E, Ruggeri, P, Minutoli, F, Rodolico, C, Mazziotti, S, Milardi, D, Musumeci, O, Toscano, A. Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function. Mol Genet Metab. 2013; 110(3): 290\u20136.","DOI":"10.1016\/j.ymgme.2013.06.023"},{"key":"114","doi-asserted-by":"crossref","unstructured":"114. Fukuda, T, Ewan, L, Bauer, M, Mattaliano, RJ, Zaal, K, Ralston, E, Plotz, PH, Raben, N. Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease. Ann Neurol. 2006; 59(4): 700\u20138.","DOI":"10.1002\/ana.20807"},{"key":"115","doi-asserted-by":"crossref","unstructured":"115. Fukuda, T, Roberts, A, Ahearn, M, Zaal, K, Ralston, E, Plotz, PH, Raben, N. Autophagy and lysosomes in Pompe disease. Autophagy. 2006; 2(4): 318\u201320.","DOI":"10.4161\/auto.2984"},{"key":"116","doi-asserted-by":"crossref","unstructured":"116. Nascimbeni, AC, Fanin, M, Masiero, E, Angelini, C, Sandri, M. Impaired autophagy contributes to muscle atrophy in glycogen storage disease type II patients. Autophagy. 2012; 8(11): 1697\u2013700.","DOI":"10.4161\/auto.21691"},{"key":"117","doi-asserted-by":"crossref","unstructured":"117. Webb, RC. Smooth muscle contraction and relaxation. Adv Physiol Educ. 2003; 27(1-4): 201\u20136.","DOI":"10.1152\/advances.2003.27.4.201"},{"key":"118","doi-asserted-by":"crossref","unstructured":"118. Chan, J, Desai, AK, Kazi, ZB, Corey, K, Austin, S, Hobson-Webb, LD, Case, LE, Jones, HN, Kishnani, PS. The emerging phenotype of late-onset Pompe disease: A systematic literature review. Mol Genet Metab. 2017; 120(3): 163\u201372.","DOI":"10.1016\/j.ymgme.2016.12.004"},{"key":"119","doi-asserted-by":"crossref","unstructured":"119. Yanovitch, TL, Banugaria, SG, Proia, AD, Kishnani, PS. Clinical and histologic ocular findings in pompe disease. J Pediatr Ophthalmol Strabismus. 2010; 47(1): 34\u201340.","DOI":"10.3928\/01913913-20100106-08"}],"container-title":["Journal of Smooth Muscle Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsmr\/54\/0\/54_0494\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T10:21:38Z","timestamp":1573986098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsmr\/54\/0\/54_0494\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":119,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1540\/jsmr.54.100","relation":{},"ISSN":["0916-8737","1884-8796"],"issn-type":[{"value":"0916-8737","type":"print"},{"value":"1884-8796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}